ELEVATION ONCOLOGY INC (ELEV) Forecast, Price Target & Analyst Ratings

NASDAQ:ELEV • US28623U1016

Current stock price

0.365 USD
-0.01 (-2.12%)
At close:
0.377 USD
+0.01 (+3.29%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELEVATION ONCOLOGY INC (ELEV).

Forecast Snapshot

Consensus Price Target

Price Target
$1.52
+ 317.31% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 6, 2025
Period
Q2 / 2025
EPS Estimate
-$0.23
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
72.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.52
Upside
+ 317.31%
From current price of $0.37 to mean target of $1.52, Based on 14 analyst forecasts
Low
$0.36
Median
$0.38
High
$7.35

Price Target Revisions

1 Month
0.00%
3 Months
-27.16%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ELEV. The average price target is 1.52 USD. This implies a price increase of 317.31% is expected in the next year compared to the current price of 0.365.
The average price target has been revised downward by 27.16% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELEV Current Analyst RatingELEV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ELEV Historical Analyst RatingsELEV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
72.86%
ELEV was analyzed by 14 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about ELEV.
In the previous month the buy percentage consensus was at a similar level.
ELEV was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-10JMP SecuritiesReiterate Market Perform -> Market Perform
2025-06-10HC Wainwright & Co.Downgrade Buy -> Neutral
2025-06-09William BlairDowngrade Outperform -> Market Perform
2025-03-24Stephens & Co.Downgrade Overweight -> Equal-Weight
2025-03-21Citizens Capital MarketsDowngrade Market Outperform -> Market Perform
2025-03-21Leerink PartnersDowngrade Outperform -> Market Perform
2025-03-21Piper SandlerDowngrade Overweight -> Neutral
2025-03-21HC Wainwright & Co.Maintains Buy -> Buy
2025-03-10Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-03-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-07Stephens & Co.Reiterate Overweight -> Overweight
2025-01-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-03William BlairInitiate Outperform
2024-12-19JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-12-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-06Stephens & Co.Reiterate Overweight -> Overweight
2024-08-07HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-15JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-06-28JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-05-31Piper SandlerInitiate Overweight
2024-05-14Stephens & Co.Initiate Overweight
2024-05-03WedbushReiterate Outperform -> Outperform
2024-04-09HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-07JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-03-07WedbushMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 6, 2025
Period
Q2 / 2025
EPS Estimate
-$0.23
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-27.22%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-29.48%

Next Earnings Summary

ELEV is expected to report earnings on 8/6/2025. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ELEV revenue by date.ELEV revenue by date.
N/AN/AN/AN/AN/A
290.98%		N/A
-100.00%		N/AN/A
362.07%
EBITDA
YoY % growth
ELEV ebitda by date.ELEV ebitda by date.
-5.88M-17.26M
-193.54%		-32.03M
-85.57%		-94.52M
-195.10%		-40.299M
57.36%		-44.679M
-10.87%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ELEV ebit by date.ELEV ebit by date.
-5.88M-17.28M
-193.88%		-32.05M
-85.47%		-94.55M
-195.01%		-40.338M
57.34%		-44.703M
-10.82%		N/A
3.43%		N/A
-14.63%		N/A
-26.79%		N/A
9.11%		N/A
-15.20%		N/A
-14.04%		N/A
26.31%		N/A
139.96%
Operating Margin
ELEV operating margin by date.ELEV operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ELEV eps by date.ELEV eps by date.
N/AN/AN/A-4.09
-63.80%		-1.53
62.59%		-0.81
47.06%		N/A
7.71%		N/A
26.01%		N/A
15.17%		N/A
34.78%		N/A
140.00%		N/A
979.17%		N/A
89.58%		N/A
16.90%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth		-0.23
-27.22%		-0.14
36.95%		-0.14
21.94%		-0.16
32.85%		-0.27
-18.04%		-0.28
-98.53%		-0.27
-91.17%		-0.35
-115.19%		-0.35
-28.30%		-0.36
-29.63%
Revenue
Q2Q % growth		N/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-14.462M
-31.91%		-8.301M
37.25%		-8.453M
20.57%		-5.712M
47.31%		-19.788M
-36.83%		-21.216M
-155.58%		-21.165M
-150.37%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELEV Yearly Revenue VS EstimatesELEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2031 2032 20M 40M 60M 80M 100M
ELEV Yearly EPS VS EstimatesELEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.42%
EPS Next 5 Year
16.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELEVATION ONCOLOGY INC / ELEV Forecast FAQ

What do analysts expect the price target to be for ELEVATION ONCOLOGY INC (ELEV)?

14 analysts have analysed ELEV and the average price target is 1.52 USD. This implies a price increase of 317.31% is expected in the next year compared to the current price of 0.365.

When does ELEVATION ONCOLOGY INC (ELEV) report earnings?

ELEVATION ONCOLOGY INC (ELEV) will report earnings on 2025-08-06, before the market open.

What are the consensus estimates for ELEV stock next earnings?

The consensus EPS estimate for the next earnings of ELEVATION ONCOLOGY INC (ELEV) is -0.23 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for ELEV stock?

The number of analysts covering ELEVATION ONCOLOGY INC (ELEV) is 14.